NIV for obesity hypoventilation syndrome

The main goals of treatment for OHS patients are as follows:

• Normalise arterial carbon dioxide tension (PaCO₂ 45 mm Hg)
• Prevent hypoxemia during sleep and wakefulness
• Prevent erythrocytosis, pulmonary hypertension, and respiratory failure
• Relieve hypersomnia and altered mentation

Treatment with NIV helps to achieve these goals, and has been widely observed to be the ideal treatment for OHS. ¹

The following ResMed devices are used to treat obesity hypoventilation syndrome:

• S9 VPAP™ ST-A
• Stellar™ 150
• Lumis™ series